Prostate Cancer Screening: What We Have Learned from the PLCO and ERSPC Trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-010-0109-5.pdf
Reference13 articles.
1. American Cancer Society: Cancer Facts and Figures 2009. Atlanta, GA: 2009. Available at http://www.cancer.org/downloads/STT/500809web.pdf .
2. • Bill-Axelson A, Holmberg L, Ruutu M, et al.: Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005, 352:1977–1984. This report comes from the first randomized study to demonstrate a survival benefit for radical prostatectomy over conservative management.
3. United States Preventive Services Task Force: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 149:185–191.
4. •• Andriole GL, Crawford ED, Grubb RL, et al.: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009, 360:1310–1319. This is the interim report from the PLCO trial, which includes a good discussion of some of the drawbacks of this study.
5. •• Schroder FH, Hugosson J, Roobol MJ, et al.: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009, 360:1320–1328. This is the ERSPC report, which shows a cancer-specific survival benefit for prostate cancer screening.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using Longitudinal Health Records to Simulate the Impact of National Treatment Guidelines for Cardiovascular Disease;2021 Winter Simulation Conference (WSC);2021-12-12
2. PSA et IRM: comment s’en servir de façon raisonnable pour la détection du cancer de la prostate;Urologie in der Praxis;2020-11-16
3. The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials;Cancer;2017-12-06
4. Prediction of Life Expectancy in Prostate Cancer Patients Based on the Kinetic Theory of the Aging of Living Systems;Advances in Gerontology;2017-10
5. Health Policy for Prostate Cancer: PSA Screening as Case Study;Prostate Cancer;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3